Browse diseases

….2% but not everyone at risk was tested. Some declined germline Lynch syndrome testing due to a lack of at-risk family members and delay getti…

… missing variables. Bradley et al developed a BN on survival in pancreatic ductal adenocarcinoma and evaluated the impact of at least two missing variables on t…

…ommended and implemented as a standard of care in patients with endometrial cancer (EC); however, few such studies have been published on Canadian…

…tic alternatives (ETAs) for patients with advanced or recurrent dMMR EC, through an adjusted indirect treatment comparison (ITC).Mat…

…chemotherapy for the treatment of advanced or recurrent EC with pMMR. Eligible studies requirements: comparable populations, consist…

…ng a delay in surgery due to treatment-related toxicity, namely myositis. A pathological response was observed in 98% of patients, with …

…Background Endometrial Cancer (EC) is the most common gynecologic malignancy in the United St…

…OTS using GFP-LNPs and cGASΔN-LNPs.Methods Tumors resected from endometrial cancer patients (n=5) were processed into PDOTS, loaded into microflui…

… Up to one in two people will develop cancer in their lifetime. Cancer is a genomic disease. While the word ‘cancer’ represents a mult…

…, is considered a precursor lesion for endometrial cancer (EC). Polycystic ovary syndrome (PCOS) is a recognised risk factor for the development of EH an…

…nce in the prevalence of heterozygous carriers in patients with endometrial cancer or OC compared to controls. ATMc.7374_7375insAlu carriers share…

…Objectives Endometrial cancer (EC) incidence has been rising globally, while mortality has re…